April 9th 2020, 6:43pm
Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19).
April 2nd 2020, 9:42pm
Vitamin D deficiency in women with gestational diabetes mellitus (GDM) is associated with an elevated risk of postpartum glucose intolerance, according to a study published in Endocrinology and Metabolism.
February 25th 2020, 9:45pm
Abbott recently announced a partnership with Insulet Corporation to integrate its glucose-sensing technology with an automated insulin delivery system for patients with diabetes. Specifically, Abbott’s FreeStyle Libre system will become compatible with Insulet’s Omnipod Horizon, in an effort to “offer personalized automated insulin delivery and care for people living with diabetes.”
August 28th 2019, 10:32pm
Coverage from the July 11, 2019, meeting of the Institute for Value-Based Medicine®, an initiative of The American Journal of Managed Care®. The meeting took place in Arlington, Virginia.
June 30th 2019, 8:21pm
The Los Angeles gathering of the Institute for Value-Based Medicine focused on the need to intervene early in the course of diabetes, so that patients can avoid long-term complications. Over the past decade, cardiovascular outcomes trials for glucose-lowering therapies have revealed unexpected benefits, offering new opportunities for cardiologists.
June 18th 2019, 1:37am
Merck's Center for Observational and Real-World Evidence has spent several years gathering evidence on clinical inertia and is now working on solutions to overcome it at the point of care.
June 14th 2019, 12:24am
The consensus report was presented at the 79th Scientific Sessions of the American Diabetes Association in San Francisco, California.
June 10th 2019, 10:38pm
Patients with type 2 diabetes (T2D) who had been using insulin an average of 8 years and had mean glycated hemoglobin (A1C) levels of 8.9% were able to bring their levels down 0.9% after 3 months, according to chart review data from 3 European countries.
June 7th 2019, 8:47pm
Aetion announced the company partnered with Horizon Healthcare Services to identify high-risk patients and optimal treatment pathways as a means to achieve better health outcomes and cut healthcare costs.
June 3rd 2019, 8:55pm
The authors, from the CDC, say that while the decline in diabetes incidence occurred alongside public health efforts, it's too soon to assume a causal relationship.
